Presentation: Kit containing 05 lyophilized reagent vials for injectable use. Sterile product, apirogenic and under nitrogen atmosphere for complexation with the radioisotope technetium-99 metastable (99mTc).

Indications: Used primarily in myocardial scintigraphy for evaluation of acute infarction and the extent of the necrosis process. Can be used as a skeletal imaging agent to demonstrate areas of altered osteogenesis. It can also be used as an agent for blood pool imaging, ventriculography, and investigations of
when administered 20-30 minutes prior to blood staining.

Storage: 2-8 °C.
Labeling volume: 1-3 mL.
Labeling activity: up to 100 mCi

Postlabeling Stability: 04 hours in room temperature (15 °C – 30 °C).
Expiry date: 12 months.
Number of vials per kit: 5

Registry: MS. 1.7359.0006.001-0

Contraindication, warnings and precautions, drug dose: see the package insert.

RPHPharma products are available only under prescription by a licensed health professional.

The content of this page is intended for health professionals